Katarina Mirjačić Martinović

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić et al. · Clinical & Experimental Metastasis · 2007 · 91 citations

Life Sciences, Immunology, Oncology +14

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

Gordana Konjević, Katarina Mirjačić Martinović, Vladimir Jurišić et al. · Biomarkers · 2009 · 73 citations

Life Sciences, Immunology, Oncology +17

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

Katarina Mirjačić Martinović, Nada Babović, Radan Džodić et al. · Melanoma Research · 2014 · 56 citations

Life Sciences, Immunology, Oncology +16

Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma

Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović et al. · Journal of Clinical Pathology · 2016 · 51 citations

Life Sciences, Immunology, Oncology +17

Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients

Katarina Mirjačić Martinović, Nada Babović, Radan Džodić et al. · Journal of Translational Medicine · 2015 · 47 citations · Full text

Life Sciences, Immunology, Oncology +17